- Home
- CIVI vs HCM Comparison
CIVI vs HCM Comparison
Compare CIVI & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIVI
- HCM
- Stock Information
- Founded
- CIVI 1999
- HCM 2000
- Country
- CIVI United States
- HCM Hong Kong
- Employees
- CIVI N/A
- HCM N/A
- Industry
- CIVI Oil & Gas Production
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- CIVI Energy
- HCM Health Care
- Exchange
- CIVI Nasdaq
- HCM Nasdaq
- Market Cap
- CIVI 2.5B
- HCM 2.5B
- IPO Year
- CIVI 2011
- HCM N/A
- Fundamental
- Price
- CIVI $32.39
- HCM $14.84
- Analyst Decision
- CIVI Buy
- HCM Hold
- Analyst Count
- CIVI 12
- HCM 1
- Target Price
- CIVI $49.60
- HCM $19.00
- AVG Volume (30 Days)
- CIVI 2.3M
- HCM 90.6K
- Earning Date
- CIVI 07-31-2025
- HCM 07-30-2025
- Dividend Yield
- CIVI 6.17%
- HCM N/A
- EPS Growth
- CIVI 5.61
- HCM N/A
- EPS
- CIVI 8.73
- HCM 0.04
- Revenue
- CIVI $5,071,808,000.00
- HCM $630,201,000.00
- Revenue This Year
- CIVI N/A
- HCM $14.86
- Revenue Next Year
- CIVI N/A
- HCM $19.54
- P/E Ratio
- CIVI $3.71
- HCM $66.84
- Revenue Growth
- CIVI 22.15
- HCM N/A
- 52 Week Low
- CIVI $22.79
- HCM $11.51
- 52 Week High
- CIVI $74.04
- HCM $21.50
- Technical
- Relative Strength Index (RSI)
- CIVI 60.80
- HCM 46.89
- Support Level
- CIVI $31.94
- HCM $15.02
- Resistance Level
- CIVI $34.25
- HCM $18.00
- Average True Range (ATR)
- CIVI 1.48
- HCM 0.42
- MACD
- CIVI 0.43
- HCM -0.04
- Stochastic Oscillator
- CIVI 74.97
- HCM 31.45
About CIVI Civitas Resources Inc.
Civitas Resources Inc is an independent exploration and production company engaged in the acquisition, development, and production of oil and associated liquids-rich natural gas in the Rocky Mountain region, in the Denver-Julesburg Basin of Colorado - DJ Basin. The company's operations are focused on developing the horizontal Niobrara and Codell formations that have a low-cost structure, mature infrastructure, production efficiencies, multiple producing horizons, multiple service providers, established reserves, and prospective drilling opportunities.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.